Company Monitoring Page for JNJ

latest headlines for company on cafepharma

Johnson & Johnson At Multi-Year Highs Ahead Of 4Q Earnings
Seeking Alpha
Mon, 01/21/13 - 10:51 am
Tags:
earnings, JNJ
4 Can't-Miss Health-Care Events This Week
Motley Fool
Mon, 01/21/13 - 10:48 am
Tags:
Impax Labs, GSK, Rytary, Parkinson's Disease, JNJ, earnings, Intuitive Surgical
Johnson and Johnson's Earnings Should Confirm What a Great Company it Is
Motley Fool
Wed, 01/16/13 - 09:06 am
Tags:
JNJ, earnings
Johnson & Johnson In 2013: New Revenue Sources And Old OTC Troubles Winding Down
Seeking Alpha
Wed, 01/16/13 - 07:56 am
Tags:
JNJ, recalls
Can J&J Get Its Diabetes Drug Past the Safety-First FDA?
Motley Fool
Mon, 01/14/13 - 12:00 pm
Tags:
JNJ, diabetes, FDA, canagliflozin
1 Great Dividend You Can Buy Right Now
Motley Fool
Sat, 01/12/13 - 11:17 am
Tags:
JNJ
Can J&J Get Its Diabetes Drug Past the Safety-First FDA?
Motley Fool
Sat, 01/12/13 - 11:05 am
Tags:
JNJ, canagliflozin, diabetes, type 2 diabetes
J&J's Prostate Cancer Drug Zytiga Approved for Earlier Use in EU
Motley Fool
Sat, 01/12/13 - 11:04 am
Tags:
JNJ, Zytiga, prostate cancer
4 Healthcare Stock Stories for Investor Wellbeing
Wall Street Cheat Street
Sat, 01/12/13 - 10:59 am
Tags:
JNJ, Telik, AbbVie, Pfizer
J&J Failed to Warn of Vaginal Mesh Risks, Lawyer Says
Bloomberg
Fri, 01/11/13 - 11:40 am
Tags:
JNJ, vaginal mesh
FDA Panel Backs Novel Diabetes Pill From J&J
Motley Fool
Fri, 01/11/13 - 11:38 am
Tags:
FDA, advisory panels, JNJ, diabetes, canagliflozin
J&J Diabetes Drug Faces Questions at FDA Advisory Panel
Motley Fool
Thu, 01/10/13 - 09:49 am
Tags:
diabetes, FDA, JNJ, advisory panel, canagliflozin
Should Any Big Pharma Buy Bausch & Lomb?
Motley Fool
Thu, 01/10/13 - 09:48 am
Tags:
M&A, Bausch & Lomb, Pfizer, Sanofi, JNJ, Abbott, Merck
4 Biotechnology Stocks With Upcoming Catalysts
Seeking Alpha
Wed, 01/9/13 - 10:06 am
Tags:
Vivus, Peregrine Pharmaceuticals, JNJ, Cellceutix
J&J Diabetes Pill May Have Heart Risks, FDA Staff Says
Bloomberg
Tue, 01/8/13 - 09:01 am
Tags:
FDA, diabetes, JNJ, Invokana
Sanofi Buys Rolaids, Plans Product Relaunch in 2013
Motley Fool
Mon, 01/7/13 - 06:53 pm
Tags:
Rolaids, Sanofi, M&A, OTC, antacids, JNJ
Big News for These 2 Diabetes Hopefuls
Motley Fool
Mon, 01/7/13 - 06:52 pm
Tags:
diabetes, empagliflozin, Eli Lilly, Invokana, JNJ
3 Big Stories Health-Care Investors Should Be Watching This Week
Motley Fool
Mon, 01/7/13 - 10:23 am
Tags:
JNJ, Invokana, SLGT-2 inhibitors, diabetes, Forxiga, Bristol-Myers Squibb, Pfizer, Raptor Pharmaceuticals
J&J Faces First Vaginal Mesh Implant Trial in New Jersey
Bloomberg
Mon, 01/7/13 - 10:21 am
Tags:
JNJ, vaginal mesh
Abbott, J&J, Sanofi Said to Show Bausch & Lomb Interest
Bloomberg
Fri, 01/4/13 - 09:53 am
Tags:
Abbott Labs, JNJ, Sanofi, Bausch & Lomb, M&A

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.